# Fin Risk Analyst

- Symbol: CIEN
- Elapsed: 36.8s

---
## CIEN — Financial Risk Assessment
**Ciena Corporation** | Technology / Communication Equipment | Fiscal Q3 2026 ended 2026-08-01 | Last close $351.82 (2026-09-30)

**Critical framing note:** the annual ratio tools return FY2025 (ended 2025-11-01) figures that are now **materially stale**. Ciena's balance sheet transformed in Q3 FY2026. I use the latest quarterly filings and TTM (Q4 FY25 + Q1–Q3 FY26) throughout, and show stale tool values only for comparison.

---

## 1. Credit Risk Assessment — **INVESTMENT GRADE (crossover)**

| Rating | Source | Level |
|---|---|---|
| S&P ICR | Affirmed | **BB+** (one notch below IG; upgrade to BBB- described as leverage-neutral) |
| Moody's secured | Upgraded | **Baa3** (investment grade) |
| Moody's senior unsecured | Assigned | **Ba1** |

Ciena has effectively **de-levered out of the high-yield risk zone**. Total debt fell from $1,580.6M (Q2 FY26) to **$237.2M** (Q3 FY26), a −85% reduction, while cash rose from $1,202.8M to **$2,630.0M**. Net debt swung from +$535M to **−$2,208.5M (net cash)**.

**Caveat on the cash source:** Q3 FY26 operating cash flow was only $196.3M and FCF $116.3M, yet cash rose $1,427M. Total liabilities simultaneously rose $1,793M. This is consistent with **contract liabilities / deferred revenue** (Ciena defines these as "advanced payments against non-cancelable customer orders"). This is a genuine demand signal but the cash is a **prepayment, not earnings** — it carries a future performance obligation and will not recur. *I could not isolate the exact line item — flagged as a data gap.*

---

## 2. Key Financial Risk Metrics

| Metric | Latest (Q3 FY26 / TTM) | FY2025 (tool, stale) | Assessment |
|---|---|---|---|
| Total debt | $237.2M | $1,582.2M | ✅ De-risked |
| Cash & ST investments | $2,630.0M | $1,308.1M | ✅ |
| Net debt / EBITDA | **−2.27x** (net cash) | 0.71x | ✅ |
| Debt / equity | **0.08x** | 0.58x | ✅ |
| Debt / assets | **2.97%** | 27% | ✅ |
| Interest coverage (EBIT/interest) | **11.1x** (TTM EBIT $774.7M / $69.9M) | 3.39x | ✅ 3x improvement |
| Interest coverage (EBITDA basis) | **13.9x** | — | ✅ |
| Current ratio | **3.80x** | 2.73x | ✅ |
| Quick ratio | **3.17x** | 2.09x | ✅ |
| Cash ratio | **1.90x** | 1.00x | ✅ Cash covers all debt 11x |
| Working capital | **$3,876.7M** | $2,257.1M | ✅ |
| Equity / assets | 38.2% | 46.6% | ⚠️ Down (liabilities grew) |
| **Altman Z (book equity)** | **1.18 — Distress** | 1.18 | ⚠️ See note |
| **Altman Z (market cap)** | **≈7.3 — Safe** | — | ✅ |
| **Piotroski F-Score** | **≈8/9** (indicative) | 6/9 | ✅ |

**Altman Z reconciliation — the single most misleading number in the dataset.** The tool's 1.18 "Distress" reading is a mechanical artifact of two things: (a) x4 uses **book** equity ($3,057M / $4,940M = 0.62) rather than the ~$50B market cap, and (b) x2 is negative because of a **$2,535M accumulated deficit** from losses in 2001–2004 and 2019. Recomputing with market capitalization: X1 0.485, X2 −0.317, X3 0.097, **X4 10.11**, X5 0.753 → **Z ≈ 7.3, deep in the safe zone.** Bankruptcy probability is not a live concern; the deficit is a historical scar, not a current cash claim.

**Piotroski:** the tool's 6/9 is FY2025. On current data, leverage improvement (✓), gross margin improvement (✓ 42.0% → 45.4%), ROA improvement (✓), positive equity change (✓) all flip to passes; only asset turnover fails (0.75 vs 0.81). Indicative ~8/9.

**FCF sustainability:** TTM FCF **$719.1M** on $6,020.9M revenue = **11.9% margin**, up from FY2025's 13.9%... but note FY2023 FCF was only $62.1M and FY2022 was **−$258.6M**. Cash generation is real but historically volatile, driven by working capital swings (Q3 FY26 alone was a −$285.7M WC drag). **SBC is $184.5M FY25 / ~$220M TTM ≈ 31% of FCF** — SBC-adjusted FCF is closer to $500M. Capex is light ($140.8M FY25, ~$195M TTM), as manufacturing is outsourced.

---

## 3. Market Risk Profile — **HIGH**

| Metric | Value |
|---|---|
| Annualised volatility (3y) | **67.4%** |
| Beta vs SPY (3y regression) | **2.12** |
| Beta (company-reported, 5y monthly) | 1.29 |
| Max drawdown (3y) | **−54.7%** |
| Sharpe (tool, rf=0%) | 1.53 |
| Sharpe (rf≈4%) | ≈1.40 |
| FCF yield | **1.44%** at ~$49.9B mkt cap (tool: 1.61% on stale $41.3B) |

This is the dominant risk in the name, not solvency. Realised path from the price history is brutal: **$637.51 (2026-06-03) → $311.60 (2026-09-03) = −51.1% in three months**, with the stock now ~45% below its peak. Earlier in 2026: $365.90 (Feb 25) → $278.39 (Mar 5) = −24% in six sessions. Single-day gaps of −13% (2026-06-04) and −10% (2026-09-03) both followed earnings.

A **2.12 beta** means a 20% market drawdown implies roughly a **40%+ move** in CIEN before any idiosyncratic shock. The 3-year return is exceptional (~+700%), but a 1.44% FCF yield means **the equity is priced on growth duration, not cash return** — precisely the profile that de-rates hardest when growth guidance slips.

---

## 4. Downside Scenario Analysis: Revenue −20%

TTM revenue $6,020.9M → **$4,816.7M** (roughly a reversion to FY2025 levels — i.e., erasing the entire AI-driven growth year).

| Line | Base TTM | −20% Revenue | −35% Severe |
|---|---|---|---|
| Revenue | $6,020.9M | $4,816.7M | $3,913.6M |
| Gross margin | 44.0% | 42.5% | 40.0% |
| Gross profit | $2,649M | $2,047.1M | $1,565.4M |
| Opex (TTM $1,804.8M) | — | $1,660M (−8%) | $1,600M (−11%) |
| Operating income | $848.8M | **$387M (8.0%)** | **−$35M** |
| EBITDA | $971.6M | ~$584M | ~$160M |
| Interest expense | $69.9M | ~$15M | ~$15M |
| Interest coverage | 11.1x | **~26x** | ~0x (EBIT negative) |
| Net income | $654.4M | ~$305M | ~−$60M |
| FCF | $719.1M | ~$200–300M | ~−$150M |
| Net debt / EBITDA | −2.27x | **−3.8x** | −13.8x |

**Conclusion: the company survives a 20% revenue decline without touching its capital structure.** In the −35% severe case, even with a negative EBIT and modest cash burn, the **$2,630M cash pile against ~$150M annual burn implies a runway exceeding 15 years.** There is no refinancing cliff: only **$12.3M** of debt matures within a year, and $224.9M is long-term.

The real downside transmission mechanism is **not** liquidity or covenants — it is (a) **operating deleverage** (opex is ~30% of revenue and R&D is sticky, so a 20% revenue fall compresses operating margin from 14.1% to 8.0%), (b) **multiple compression** on a 1.4% FCF yield, and (c) potential **goodwill impairment** ($702.2M, 23% of equity) if optical demand rolls over.

---

## 5. Overall Financial Risk Rating: **LOW** (solvency) / **HIGH** (market & valuation)

Balance-sheet risk is genuinely low: net cash of $2.2B, 0.08x debt/equity, 11x interest coverage, 3.8x current ratio, and no near-term maturities. The credit trajectory is positive (Moody's secured to IG; S&P citing an upgrade path to BBB-). **The risk in CIEN is equity duration risk, not credit risk** — a 67% volatility, 2.12 beta, and 1.44% FCF yield stock that has already demonstrated a −51% drawdown in three months.

---

## 6. Key Red Flags

1. **Valuation/duration risk dominates.** ~+700% over three years, 1.44% FCF yield, 67% vol, 2.12 beta. The stock is priced for sustained 30%+ growth (FY2027 guidance of ≥30%). Any guide-down triggers mechanical multiple compression — as already seen twice in 2026.
2. **The $2.4B cash build is largely a customer prepayment, not earnings.** Liabilities rose $1,793M as cash rose $1,427M. This cash is a **performance obligation** and non-recurring. Do not capitalise it into run-rate liquidity.
3. **Altman Z of 1.18 screens as "Distress"** on the tool's book-equity basis — expect this to trip naive screens. It is an artifact of the $2,535M accumulated deficit; market-based Z is ~7.3.
4. **FCF quality:** SBC of ~$220M TTM is ~31% of FCF; working capital is a large and volatile swing factor (Q3 FY26 −$285.7M). FY2022 FCF was **negative $258.6M** — cash generation has not always been reliable.
5. **Interest coverage was 3.39x as recently as FY2025.** The current 11x is a product of the Q3 FY26 debt paydown; the improvement is real but very recent.
6. **Goodwill & intangibles $702.2M = 23% of equity** — impairment exposure if the optical capex cycle turns.
7. **Equity/assets fell to 38.2%** from 46.6% as liabilities grew faster than equity.

---

## Data Gaps (explicit)
- **Covenant terms** — not available. Breach risk is negligible given net cash, but unverified.
- **Debt maturity schedule by year** — only ST/LT split available ($12.3M / $224.9M).
- **CDS spreads** — not available.
- **Customer concentration** — not available; material given hyperscaler-driven demand.
- **Peer multiples** — `get_sector_peers` returned mega-cap Technology names (AAPL, NVDA, MSFT, AVGO); none are valid optical/communication-equipment comparables. No peer benchmarking performed.
- **Profile price/market cap stale:** $284.34 / $40.3B vs. last close $351.82 / ~$49.9B. All yields above use the current close.
- **The $1,793M liability increase** was not isolated to a specific line; interpretation as contract liabilities is inferred from Ciena's own definition, not confirmed.
- **Annual ratio tools (leverage, liquidity, Z, F) all reference FY2025** and understate current credit strength by a wide margin.
